Risperidone in levodopa-induced psychosis in advanced Parkinson's disease: an open-label, long-term study.
Meco
G
G
Department of Neurological Sciences, La Sapienza University Roma, Italy.
Alessandri
A
A
Giustini
P
P
Bonifati
V
V
D000368:Aged; D014150:Antipsychotic Agents / Q000627:therapeutic use*; D018450:Disease Progression; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007980:Levodopa / Q000008:administration & dosage / Q000009:adverse effects*; D008297:Male; D010300:Parkinson Disease / Q000150:complications / Q000188:drug therapy*; D011605:Psychoses, Substance-Induced / Q000188:drug therapy*; D018967:Risperidone / Q000627:therapeutic use*; D012720:Severity of Illness Index; D013997:Time Factors
D014150:Antipsychotic Agents; D007980:Levodopa; D018967:Risperidone